Zobrazeno 1 - 2
of 2
pro vyhledávání: '"D A, Albreski"'
Publikováno v:
Postgraduate medicine.
With exciting recent developments in the field of medical mycology and a new generation of oral antifungal agents, there has been renewed interest in the management of onychomycosis. Epidemiologic surveys report an overall disease prevalence of 2% to
Autor:
E G Gross, D A Albreski
Publikováno v:
Journal of the American Podiatric Medical Association. 89(7)
This study examined the safety of itraconazole for the treatment of onychomycosis in patients with diabetes mellitus compared with standard palliative treatment. Fifty-two diabetic subjects in a large Veterans Affairs health system who had been diagn